Skip to content

The Application Value of Left Bundle Branch Area Pacing in Patients with Chronic Heart Failure and Intraventricular Conduction Block (BATTLE study)

The Application Value of Left Bundle Branch Area Pacing in Patients with Chronic Heart Failure and Intraventricular Conduction Block (BATTLE study)

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600125321
Enrollment
Unknown
Registered
2026-05-25
Start date
2023-09-20
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart failure, nonspecific intraventricular conduction delay

Interventions

BiVP group:bi-ventricular pacing
LOT-CRT group:left Bundle branch optimized cardiac resynchronization Therapy

Sponsors

Jiangsu Province Hospital (The First Affiliated Hospital with Nanjing Medical University)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Ischemic or non ischemic cardiomyopathy; 2. Optimal medical therapy for at lest 3 months; 3. NYHA class II-IV; 4. 18-80 years old; 5. LVEF=35% as assessed by echocardiography; 6. Sinus rhythm (may have paroxysmal atrial fibrillation); 7. QRS duration =150ms; 8. Intraventricular block (NICD), QRS morphology is neither LBBB nor RBBB;

Exclusion criteria

Exclusion criteria: 1. Valvular heart disease that requires or has undergone surgical intervention; 2. After mechanical tricuspid valve replacement; 3. Persistent or permanent atrial fibrillation or atrial flutter; 4. Second or third degree atrioventricular block; 5. Have a history of acute myocardial infarction within 3 months prior to enrollment; 6. Patient's expected survival time is less than 12 months; 7. Pregnant or planned to conceive; 8. Ventricular septal hypertrophy (ventricular septal thickness exceeds 15mm at the end of diastole); 9. Patients with simple and persistent left superior vena cava; 10. Patients with existing pacemaker implantation;

Design outcomes

Primary

MeasureTime frame
LVEF change;

Secondary

MeasureTime frame
New-onset atrial fibrillation and ventricular arrhythmias;LVESD change;LVESV change;LBBAP success rate;6 minute walk test;Stroke;NT-proBNP;CCS score;Hospitalization for heart failure or all-cause mortality;NYHA classification;LVEDV change;LVEDD change;Paced QRS duration;

Countries

China

Contacts

Public ContactJiangang Zou

Jiangsu Province Hospital (The First Affiliated Hospital with Nanjing Medical University)

jgzou@njmu.edu.cn+86 25 3830 3136

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jun 11, 2026